CVS241220C66000
- 0.01
- 0.000.00%
CVS Health Newsroom
CVS Health Options Spot-On: On December 19th, 133.75K Contracts Were Traded, With 900.53K Open Interest
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Baird Adjusts CVS Health Price Target to $51 From $61, Maintains Neutral Rating
Peering Into CVS Health's Recent Short Interest
Wells Fargo Trim Price Target on CVS Health to $65 From $66
PBM Reform Looks Manageable for CVS Health, Says UBS
Stock Market's Fed Reaction Is Overdone. But New -2-
Leerink Partners Maintains CVS Health(CVS.US) With Hold Rating, Cuts Target Price to $51
CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions
Aetna Adds Spanish Language Capabilities for Health App to Better Serve Diverse Populations
Dow Tanks as Powell Sends Shockwaves. This Is No Time To Panic.
CVS's 'Violations Resulted From Corporate-Mandated Performance Metrics, Incentive Compensation, and Staffing Policies That Prioritized Corporate Profits,' DOJ Alleges
CVS Pharmacy, Various Units Filled Unlawful Prescriptions in Violation of Controlled Substances Act, Justice Department Alleges
CVS Health Options Spot-On: On December 18th, 94,776 Contracts Were Traded, With 875.2K Open Interest
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
CVS Accused of Illegal Opioid Dispensing in Whistleblower Suit
Jim Cramer's Bold Take: Why CVS Health (CVS) Is Struggling in Today's Healthcare Environment
Evercore Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $75